Status:
UNKNOWN
Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Liver Disease
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of ...
Detailed Description
Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of ...
Eligibility Criteria
Inclusion
- normal volunteer
- living liver donor
Exclusion
- COPD
- chronic liver disease
- hypersensitive to glucagon
- DM
- insulinoma
- glucagonoma
- pregnancy
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00155376
Start Date
September 1 2005
End Date
September 1 2005
Last Update
November 28 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Province of Taiwan, Taiwan, 100